Aethlon Medical, Inc.
AEMD
$1.71
-$0.11-5.80%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -11.89% | -2.07% | 13.63% | -49.12% | -31.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.89% | -2.07% | 13.63% | -49.12% | -31.61% |
| Operating Income | 11.89% | 2.07% | -13.63% | 49.12% | 31.61% |
| Income Before Tax | 12.15% | 69.87% | -15.01% | 47.02% | 31.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.15% | 69.87% | -15.01% | 47.02% | 31.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.15% | 69.87% | -15.01% | 47.02% | 31.48% |
| EBIT | 11.89% | 2.07% | -13.63% | 49.12% | 31.61% |
| EBITDA | 11.90% | 1.93% | -14.42% | 50.41% | 32.55% |
| EPS Basic | 90.52% | 95.66% | 75.61% | 76.78% | 69.24% |
| Normalized Basic EPS | 90.52% | 95.58% | 75.61% | 77.30% | 69.24% |
| EPS Diluted | 90.52% | 95.66% | 75.61% | 76.78% | 69.24% |
| Normalized Diluted EPS | 90.52% | 95.58% | 75.61% | 77.30% | 69.24% |
| Average Basic Shares Outstanding | 826.99% | 592.86% | 371.63% | 128.45% | 123.12% |
| Average Diluted Shares Outstanding | 826.99% | 592.86% | 371.63% | 128.45% | 123.12% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |